You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Dow
Johnson and Johnson
Mallinckrodt

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Parathyroid hormone - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for parathyroid hormone

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Daniel HorwitzPhase 4
Radius Health, Inc.Phase 4
University of South CarolinaPhase 4

See all parathyroid hormone clinical trials

Recent Litigation for parathyroid hormone

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Juul Labs Inc v. EZfumes2020-07-10
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
Silvergate Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC2019-04-11

See all parathyroid hormone litigation

PTAB Litigation
PetitionerDate
2018-07-13
2017-07-28
Pfizer, Inc.2017-05-19

See all parathyroid hormone litigation

Pharmacology for parathyroid hormone
Ingredient-typeParathyroid Hormone

Company Disclosures: US Patents for parathyroid hormone

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Allelix BioPharmaceuticals Inc. (Ontario, CA) 2039-03-29 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for parathyroid hormone

These patents were identified by searching patent claims

Supplementary Protection Certificates for parathyroid hormone

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017000021 Germany   Start Trial PRODUCT NAME: ETELCALCETID ODER EIN SALZ DAVON, EINSCHLIESSLICH ETELCALCETIDHYDROCHLORID; REGISTRATION NO/DATE: EU/1/16/1142 20161111
2006901381900 Italy   Start Trial AUTHORISATION NUMBER(S) AND DATE(S): EU/1/02/240/001-003, 20021113
00741 Netherlands   Start Trial PRODUCT NAME: CICLOSPORINE (EYE DROP; REGISTRATION NO/DATE: EU/1/15/990 20150319
1409016/01 Switzerland   Start Trial PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: SWISSMEDIC 60210 03.08.2010
/2005 Austria   Start Trial PRODUCT NAME: CINACALCET ODER EIN PHARMAZEUTISCH AKZEPTABLES DERIVAT ODER SALZ DESSELBEN, INSBESONDERE CINACALCET-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/04/292/001-012 20041022
2013 00015 Denmark   Start Trial
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
McKinsey
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.